Loading insider details...
Latest Form 4 (Oct 22, 2026): Purchase of 3,680 RAPP shares, $99.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 22, 2026 | Rapport Therapeutics, Inc. (RAPP) | Purchase | 3,680 | $99.6K |
| Jun 10, 2026 | Rapport Therapeutics, Inc. (RAPP) | Grant/Award | 15,200 | n/a |
| May 15, 2026 | Nurix Therapeutics, Inc. (NRIX) | Grant/Award | 31,250 | n/a |
| Jun 18, 2025 | Rapport Therapeutics, Inc. (RAPP) | Grant/Award | 10,925 | n/a |
| May 19, 2025 | Nurix Therapeutics, Inc. (NRIX) | Grant/Award | 25,000 | n/a |
| Nov 7, 2024 | Rapport Therapeutics, Inc. (RAPP) | Grant/Award | 29,756 | n/a |
| May 20, 2024 | Nurix Therapeutics, Inc. (NRIX) | Grant/Award | 25,000 | n/a |
| May 5, 2023 | Nurix Therapeutics, Inc. (NRIX) | Grant/Award | 25,000 | n/a |
| May 6, 2022 | Nurix Therapeutics, Inc. (NRIX) | Grant/Award | 17,500 | n/a |
| Oct 4, 2021 | Nurix Therapeutics, Inc. (NRIX) | Grant/Award | 35,000 | n/a |